Perinatal Infections Market, By Infection (Cytomegalovirus Infection, Enterovirus Infection, Genital Herpes, Gonorrhoea and Human Immunodeficiency Virus), By Diagnosis, By Treatment, By Route of Administration, By End User, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
REPORT HIGHLIGHT
Perinatal Infections Market size was valued at USD 4,125.2 Million in 2023, expanding at a CAGR of 6.00% from 2024 to 2032.
Infections that can spread from the mother to the child during pregnancy, labor, or the initial few hours after delivery are known as perinatal infections. Due to the limited ability of neonates, particularly those born preterm, to verbalize their symptoms, even slight deviations from the norm should be interpreted as an indication of bacterial disease. Pregnancy is a common time to see diseases such as listeria, bacterial vaginosis (BV), group B streptococcus (GBS), dermatitis, herpes, vaginal yeast infections, and the flu.
Perinatal Infections Market- Market Dynamics
Growing Prevalence of Perinatal Infections to Propel Market Growth
The global market for perinatal infections is expanding as a result of the rising prevalence of prenatal infections globally. The mother and the infant are both seriously threatened by these infections, which highlights the need for improved prevention, diagnostic, and treatment methods. Any time throughout pregnancy or during labor and delivery, a mother\'s health and the health of her unborn child are at danger due to perinatal infections. Human immunodeficiency virus (HIV), hepatitis B, syphilis, group B streptococcus (GBS), and chlamydia are common illnesses that can affect infants. Serious consequences include preterm birth, low birth weight, neonatal sepsis, congenital abnormalities, and mother morbidity and death can result from these infections. Furthermore, the frequency of perinatal infections is rising due to a number of causes. Undiagnosed or untreated infections are a result of inadequate access to prenatal care and scarce healthcare resources in some areas. Routine prenatal care visits are crucial to screen for and identify perinatal infections early on.Prenatal infections can result from a number of high-risk behaviors, including drug addiction, unprotected sexual activity, and having several partners. It is essential to address these habits through prevention and education initiatives.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL PERINATAL INFECTIONS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
Merck KgaA
Beckman Coulter Inc.
BIOMERIEUX
Bio-Rad Laboratories, Inc
Danaher
Hologic Inc.
Gilead Sciences, Inc.
Emcure Pharmaceuticals Limited.
Cipla Inc.
Hetero
Bausch Health Companies Inc.
Johnson & Johnson Private Limited
Mylan N.V.
Teva Pharmaceutical Industries Ltd.
Sanofi
Novartis AG
Sun Pharmaceutical Industries Ltd
Others
GLOBAL PERINATAL INFECTIONS MARKET, BY INFECTION- MARKET ANALYSIS, 2019 - 2032
Cytomegalovirus Infection
Enterovirus Infection
Genital Herpes
Gonorrhoea
Human Immunodeficiency Virus
Others
GLOBAL PERINATAL INFECTIONS MARKET, BY DIAGNOSIS- MARKET ANALYSIS, 2019 - 2032
Maternal Test
Neonatal Test
Others
GLOBAL PERINATAL INFECTIONS MARKET, BY TREATMENT- MARKET ANALYSIS, 2019 - 2032
Antibiotics
Antiviral
Antiretroviral
Others
GLOBAL PERINATAL INFECTIONS MARKET, BY ROUTE OF ADMINISTRATION- MARKET ANALYSIS, 2019 - 2032
Oral
Parenteral
Others
GLOBAL PERINATAL INFECTIONS MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032
Hospitals
Homecare
Specialty Clinics
Others
GLOBAL PERINATAL INFECTIONS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
o The U.S.
o Canada
Europe
o Germany
o France
o Italy
o Spain
o United Kingdom
o Russia
o Netherlands
o Sweden
o Poland
o Rest of Europe
Asia Pacific
o India
o China
o South Korea
o Japan
o Australia
o Thailand
o Indonesia
o Philippines
o Rest of APAC
Latin America
o Brazil
o Mexico
o Argentina
o Colombia
o Rest of LATAM
The Middle East and Africa
o Saudi Arabia
o United Arab Emirates
o Israel
o Turkey
o Algeria
o Egypt
o Rest of MEA
TABLE OF CONTENT
1. Perinatal Infections Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Perinatal Infections Market Snippet by Infection
2.1.2. Perinatal Infections Market Snippet by Diagnosis
2.1.3. Perinatal Infections Market Snippet by Treatment
2.1.4. Perinatal Infections Market Snippet by Route of Administration
2.1.5. Perinatal Infections Market Snippet by End User
2.1.6. Perinatal Infections Market Snippet by Country
2.1.7. Perinatal Infections Market Snippet by Region
2.2. Competitive Insights
3. Perinatal Infections Key Market Trends
3.1. Perinatal Infections Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Perinatal Infections Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Perinatal Infections Market Opportunities
3.4. Perinatal Infections Market Future Trends
4. Perinatal Infections Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Perinatal Infections Market: COVID-19 Impact Analysis
5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
5.2.1. Top Performing Segments
5.2.2. Marginal Growth Segments
5.2.3. Top Looser Segments
5.2.4. Marginal Loss Segments
6. Perinatal Infections Market Landscape
6.1. Perinatal Infections Market Share Analysis, 2023
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Perinatal Infections Market – By Infection
7.1. Overview
7.1.1. Segment Share Analysis, By Infection, 2023 & 2032 (%)
7.1.2. Cytomegalovirus Infection
7.1.3. Enterovirus Infection
7.1.4. Genital Herpes
7.1.5. Gonorrhoea
7.1.6. Human Immunodeficiency Virus
7.1.7. Others
8. Perinatal Infections Market – By Diagnosis
8.1. Overview
8.1.1. Segment Share Analysis, By Diagnosis, 2023 & 2032 (%)
8.1.2. Maternal Test
8.1.3. Neonatal Test
8.1.4. Others
9. Perinatal Infections Market – By Treatment
9.1. Overview
9.1.1. Segment Share Analysis, By Treatment, 2023 & 2032 (%)
9.1.2. Antibiotics
9.1.3. Antiviral
9.1.4. Antiretroviral
9.1.5. Others
10. Perinatal Infections Market – By Route of Administration
10.1. Overview
10.1.1. Segment Share Analysis, By Route of Administration, 2023 & 2032 (%)
10.1.2. Oral
10.1.3. Parenteral
10.1.4. Others
11. Perinatal Infections Market – By End User
11.1. Overview
11.1.1. Segment Share Analysis, By End User, 2023 & 2032 (%)
11.1.2. Hospitals
11.1.3. Homecare
11.1.4. Specialty Clinics
11.1.5. Others
12. Perinatal Infections Market– By Geography
12.1. Introduction
12.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
12.2. North America
12.2.1. Overview
12.2.2. Perinatal Infections Key Manufacturers in North America
12.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.2.4. North America Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
12.2.5. North America Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
12.2.6. North America Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
12.2.7. North America Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.2.8. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.2.9. U.S.
12.2.9.1. Overview
12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.2.9.3. U.S. Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
12.2.9.4. U.S. Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
12.2.9.5. U.S. Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
12.2.9.6. U.S. Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.2.9.7. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.2.10. Canada
12.2.10.1. Overview
12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.2.10.3. Canada Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
12.2.10.4. Canada Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
12.2.10.5. Canada Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
12.2.10.6. Canada Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.2.10.7. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3. Europe
12.3.1. Overview
12.3.2. Perinatal Infections Key Manufacturers in Europe
12.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.3.4. Europe Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
12.3.5. Europe Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
12.3.6. Europe Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
12.3.7. Europe Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.3.8. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.9. Germany
12.3.9.1. Overview
12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.9.3. Germany Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
12.3.9.4. Germany Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
12.3.9.5. Germany Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
12.3.9.6. Germany Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.3.9.7. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.10. Italy
12.3.10.1. Overview
12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.10.3. Italy Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
12.3.10.4. Italy Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
12.3.10.5. Italy Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
12.3.10.6. Italy Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.3.10.7. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.11. United Kingdom
12.3.11.1. Overview
12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.11.3. United Kingdom Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
12.3.11.4. United Kingdom Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
12.3.11.5. United Kingdom Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
12.3.11.6. United Kingdom Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.3.11.7. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.12. France
12.3.12.1. Overview
12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.12.3. France Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
12.3.12.4. France Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
12.3.12.5. France Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
12.3.12.6. France Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.3.12.7. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.13. Russia
12.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.13.2. Russia Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
12.3.13.3. Russia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
12.3.13.4. Russia Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
12.3.13.5. Russia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.3.13.6. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.14. Netherlands
12.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.14.2. Netherlands Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
12.3.14.3. Netherlands Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
12.3.14.4. Netherlands Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
12.3.14.5. Netherlands Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.3.14.6. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.15. Sweden
12.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.15.2. Sweden Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
12.3.15.3. Sweden Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
12.3.15.4. Sweden Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
12.3.15.5. Sweden Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.3.15.6. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.16. Poland
12.3.16.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.16.2. Poland Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
12.3.16.3. Poland Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
12.3.16.4. Poland Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
12.3.16.5. Poland Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.3.16.6. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.17. Rest of Europe
12.3.17.1. Overview
12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.17.3. Rest of the Europe Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
12.3.17.4. Rest of the Europe Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
12.3.17.5. Rest of the Europe Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
12.3.17.6. Rest of the Europe Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.3.17.7. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4. Asia Pacific (APAC)
12.4.1. Overview
12.4.2. Perinatal Infections Key Manufacturers in Asia Pacific
12.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.4.4. Asia Pacific Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
12.4.5. Asia Pacific Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
12.4.6. Asia Pacific Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
12.4.7. Asia Pacific Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.4.8. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.9. India
12.4.9.1. Overview
12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.9.3. India Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
12.4.9.4. India Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
12.4.9.5. India Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
12.4.9.6. India Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.4.9.7. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.10. China
12.4.10.1. Overview
12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.10.3. China Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
12.4.10.4. China Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
12.4.10.5. China Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
12.4.10.6. China Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.4.10.7. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.11. Japan
12.4.11.1. Overview
12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.11.3. Japan Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
12.4.11.4. Japan Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
12.4.11.5. Japan Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
12.4.11.6. Japan Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.4.11.7. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.12. South Korea
12.4.12.1. Overview
12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.12.3. South Korea Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
12.4.12.4. South Korea Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
12.4.12.5. South Korea Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
12.4.12.6. South Korea Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.4.12.7. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.13. Australia
12.4.13.1. Overview
12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.13.3. Australia Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
12.4.13.4. Australia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
12.4.13.5. Australia Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
12.4.13.6. Australia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.4.13.7. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.14. Thailand
12.4.14.1. Overview
12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.14.3. Thailand Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
12.4.14.4. Thailand Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
12.4.14.5. Thailand Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
12.4.14.6. Thailand Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.4.14.7. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.15. Indonesia
12.4.15.1. Overview
12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.15.3. Indonesia Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
12.4.15.4. Indonesia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
12.4.15.5. Indonesia Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
12.4.15.6. Indonesia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.4.15.7. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.16. Philippines
12.4.16.1. Overview
12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.16.3. Philippines Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
12.4.16.4. Philippines Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
12.4.16.5. Philippines Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
12.4.16.6. Philippines Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.4.16.7. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.17. Rest of APAC
12.4.17.1. Overview
12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.17.3. Rest of APAC Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
12.4.17.4. Rest of APAC Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
12.4.17.5. Rest of APAC Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
12.4.17.6. Rest of APAC Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.4.17.7. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5. Latin America
12.5.1. Overview
12.5.2. Perinatal Infections Key Manufacturers in Latin America
12.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.5.4. Latin America Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
12.5.5. Latin America Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
12.5.6. Latin America Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
12.5.7. Latin America Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.5.8. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5.9. Brazil
12.5.9.1. Overview
12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.9.3. Brazil Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
12.5.9.4. Brazil Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
12.5.9.5. Brazil Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
12.5.9.6. Brazil Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.5.9.7. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5.10. Mexico
12.5.10.1. Overview
12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.10.3. Mexico Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
12.5.10.4. Mexico Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
12.5.10.5. Mexico Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
12.5.10.6. Mexico Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.5.10.7. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5.11. Argentina
12.5.11.1. Overview
12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.11.3. Argentina Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
12.5.11.4. Argentina Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
12.5.11.5. Argentina Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
12.5.11.6. Argentina Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.5.11.7. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5.12. Colombia
12.5.12.1. Overview
12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.12.3. Colombia Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
12.5.12.4. Colombia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
12.5.12.5. Colombia Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
12.5.12.6. Colombia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.5.12.7. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5.13. Rest of LATAM
12.5.13.1. Overview
12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.13.3. Rest of LATAM Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
12.5.13.4. Rest of LATAM Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
12.5.13.5. Rest of LATAM Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
12.5.13.6. Rest of LATAM Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.5.13.7. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6. Middle East and Africa
12.6.1. Overview
12.6.2. Perinatal Infections Key Manufacturers in Middle East and Africa
12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.6.4. Middle East and Africa Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
12.6.5. Middle East and Africa Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
12.6.6. Middle East and Africa Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
12.6.7. Middle East and Africa Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.6.8. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.9. Saudi Arabia
12.6.9.1. Overview
12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.9.3. Saudi Arabia Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
12.6.9.4. Saudi Arabia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
12.6.9.5. Saudi Arabia Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
12.6.9.6. Saudi Arabia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.6.9.7. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.10. United Arab Emirates
12.6.10.1. Overview
12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.10.3. United Arab Emirates Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
12.6.10.4. United Arab Emirates Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
12.6.10.5. United Arab Emirates Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
12.6.10.6. United Arab Emirates Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.6.10.7. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.11. Israel
12.6.11.1. Overview
12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.11.3. Israel Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
12.6.11.4. Israel Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
12.6.11.5. Israel Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
12.6.11.6. Israel Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.6.11.7. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.12. Turkey
12.6.12.1. Overview
12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.12.3. Turkey Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
12.6.12.4. Turkey Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
12.6.12.5. Turkey Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
12.6.12.6. Turkey Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.6.12.7. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.13. Algeria
12.6.13.1. Overview
12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.13.3. Algeria Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
12.6.13.4. Algeria Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
12.6.13.5. Algeria Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
12.6.13.6. Algeria Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.6.13.7. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.14. Egypt
12.6.14.1. Overview
12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.14.3. Egypt Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
12.6.14.4. Egypt Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
12.6.14.5. Egypt Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
12.6.14.6. Egypt Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.6.14.7. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.15. Rest of MEA
12.6.15.1. Overview
12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.15.3. Rest of MEA Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
12.6.15.4. Rest of MEA Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
12.6.15.5. Rest of MEA Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
12.6.15.6. Rest of MEA Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.6.15.7. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
13. Key Vendor Analysis- Perinatal Infections Industry
13.1. Competitive Dashboard
13.2. Company Profiles
13.2.1. Merck KgaA
13.2.2. Beckman Coulter Inc.
13.2.3. BIOMERIEUX
13.2.4. Bio-Rad Laboratories, Inc
13.2.5. Danaher
13.2.6. Hologic Inc.
13.2.7. Gilead Sciences, Inc.
13.2.8. Emcure Pharmaceuticals Limited.
13.2.9. Cipla Inc.
13.2.10. Hetero
13.2.11. Bausch Health Companies Inc.
13.2.12. Johnson & Johnson Private Limited
13.2.13. Mylan N.V.
13.2.14. Teva Pharmaceutical Industries Ltd.
13.2.15. Sanofi
13.2.16. Novartis AG
13.2.17. Sun Pharmaceutical Industries Ltd
13.2.18. Others
14. 360 Degree Analyst View
15. Appendix
15.1. Research Methodology
15.2. References
15.3. Abbreviations
15.4. Disclaimer
15.5. Contact Us
